Top Markets
Coin of the day
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
株式のランク #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
株価
$5.84
最終同期: 2025-04-02
時価総額
$224.09M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Nevro Corp. (NVRO)

カテゴリー

Nevro Corp.(NVRO)の収益
Dec 2024 時点の収益 TTM: $408.52M
Nevro Corp. の最新の財務報告によると、現在の収益 (TTM) は $408.52M です。2023 年には $425.17M の収益があり、これは 2022 年の $406.37M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Nevro Corp. の収益履歴(2012 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $408.52M 0.00%
2024 $408.52M -3.92%
2023 $425.17M 4.63%
2022 $406.37M 5.03%
2021 $386.91M 6.87%
2020 $362.05M -7.23%
2019 $390.26M 0.77%
2018 $387.29M 18.56%
2017 $326.67M 42.96%
2016 $228.50M 228.28%
2015 $69.61M 113.69%
2014 $32.57M 38.61%
2013 $23.50M 29.48%
2012 $18.15M 0.00%
同業他社の収益
企業 収益 収益の差
$46.59B 11,303.41%
US
$25.84B 6,224.57%
US
$35.48B 8,586.03%
IE
$21.00B 5,039.55%
US
$6.51B 1,494.13%
US